Archive · 21 Jul 2026
IIT Kanpur Scientists Discover EP 67 Vaccine Booster
Scientists at IIT Kanpur have discovered a new vaccine booster called EP 67.
This booster helps the body's immune system recognize and fight infections better.
It works by activating special cells called dendritic cells and macrophages, which help the body remember how to fight off infections.
Importantly, EP 67 does not activate neutrophils, which are cells that can cause inflammation and side effects.
This means that vaccines with EP 67 could be stronger and safer, providing better protection without causing as many side effects.
IIT Kanpur scientists discovered EP 67, a new vaccine booster.
EP 67 selectively activates dendritic cells and macrophages.
It avoids activating neutrophils, reducing inflammation.
This could make vaccines stronger and safer.
Further research is needed to confirm long-term effects.
- Who
- Scientists at IIT Kanpur
- What
- Discovered EP 67, a vaccine booster
- When
- Not specified
- Where
- IIT Kanpur, India
- Why
- To make vaccines safer and stronger
Proponents of EP 67
Skeptics of EP 67
Efficacy and Safety
Proponents of EP 67
EP 67 selectively activates dendritic cells and macrophages, enhancing immune response without increasing inflammation.
Skeptics of EP 67
Long-term effects and potential unknown side effects need further investigation.
- Institution
- IIT Kanpur
- Discovery
- EP 67
- Target Cells
- Dendritic cells, Macrophages
- Avoids Activation
- Neutrophils
- Potential Benefit
- Stronger immune response with reduced inflammation